{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:00:04Z","timestamp":1789390804836,"version":"build-2803163510"},"reference-count":36,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2015,8,28]]},"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Angiotensin II (AngII) activates via angiotensin-II-type-I receptor (AT1R) Janus-kinase-2 (JAK2)\/Arhgef1 pathway and subsequently RHOA\/Rho-kinase (ROCK), which induces experimental and probably human liver fibrosis. This study investigated the relationship of JAK2 to experimental and human portal hypertension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>\n                      The mRNA and protein levels of JAK2\/ARHGEF1 signalling components were analysed in 49 human liver samples and correlated with clinical parameters of portal hypertension in these patients. Correspondingly, liver fibrosis (bile duct ligation (BDL), carbon tetrachloride (CCl\n                      <jats:sub>4<\/jats:sub>\n                      )) was induced in floxed-\n                      <jats:italic>Jak2<\/jats:italic>\n                      knock-out mice with SM22-promotor (SM22\n                      <jats:sup>Cre+<\/jats:sup>\n                      -\n                      <jats:italic>Jak2<\/jats:italic>\n                      <jats:sup>f\/f<\/jats:sup>\n                      ). Transcription and contraction of primary myofibroblasts from healthy and fibrotic mice and rats were analysed. In two different cirrhosis models (BDL, CCl\n                      <jats:sub>4<\/jats:sub>\n                      ) in rats, the acute haemodynamic effect of the JAK2 inhibitor AG490 was assessed using microsphere technique and isolated liver perfusion experiments.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Hepatic transcription of JAK2\/ARHGEF1 pathway components was upregulated in liver cirrhosis dependent on aetiology, severity and complications of human liver cirrhosis (Model for End-stage Liver disease (MELD) score, Child score as well as ascites, high-risk varices, spontaneous bacterial peritonitis). SM22\n                      <jats:sup>Cre+<\/jats:sup>\n                      -\n                      <jats:italic>Jak2<\/jats:italic>\n                      <jats:sup>f\/f<\/jats:sup>\n                      mice lacking\n                      <jats:italic>Jak2<\/jats:italic>\n                      developed less fibrosis and lower portal pressure (PP) than SM22\n                      <jats:sup>Cre\u2212<\/jats:sup>\n                      -\n                      <jats:italic>Jak2<\/jats:italic>\n                      <jats:sup>f\/f<\/jats:sup>\n                      upon fibrosis induction. Myofibroblasts from SM22\n                      <jats:sup>Cre+<\/jats:sup>\n                      -\n                      <jats:italic>Jak2<\/jats:italic>\n                      <jats:sup>f\/f<\/jats:sup>\n                      mice expressed less collagen and profibrotic markers upon activation. AG490 relaxed activated hepatic stellate cells in vitro. In cirrhotic rats, AG490 decreased hepatic vascular resistance and consequently the PP in vivo and in situ.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Hepatic JAK2\/ARHGEF1\/ROCK expression is associated with portal hypertension and decompensation in human cirrhosis. The deletion of\n                      <jats:italic>Jak2<\/jats:italic>\n                      in myofibroblasts attenuated experimental fibrosis and acute inhibition of JAK2 decreased PP. Thus, JAK2 inhibitors, already in clinical use for other indications, might be a new approach to treat cirrhosis with portal hypertension.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2015-309600","type":"journal-article","created":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T21:14:49Z","timestamp":1442610889000},"page":"145-155","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":61,"title":["Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis"],"prefix":"10.1136","volume":"66","author":[{"given":"Sabine","family":"Klein","sequence":"first","affiliation":[{"name":"Department of Internal Medicine I, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Rick","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Lehmann","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Schierwagen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irela Gretchen","family":"Schierwagen","sequence":"additional","affiliation":[{"name":"Institute for Cell Biology, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Len","family":"Verbeke","sequence":"additional","affiliation":[{"name":"Department of Liver and Biliopancreatic Disorders, University of Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanishka","family":"Hittatiya","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank Erhard","family":"Uschner","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Manekeller","sequence":"additional","affiliation":[{"name":"Department of General and Visceral Surgery, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian P","family":"Strassburg","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay-Uwe","family":"Wagner","sequence":"additional","affiliation":[{"name":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P","family":"Sayeski","sequence":"additional","affiliation":[{"name":"Department of Physiology and Functional Genomics, University of Florida, College of Medicine, Gainesville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Wolf","sequence":"additional","affiliation":[{"name":"Medical Clinic III, Oncology, Hematology and Rheumatology, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Laleman","sequence":"additional","affiliation":[{"name":"Department of Liver and Biliopancreatic Disorders, University of Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Sauerbruch","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonel","family":"Trebicka","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,9,17]]},"reference":[{"key":"2025112109171759000_66.1.145.1","doi-asserted-by":"crossref","unstructured":"World Health Organisation. The World Health report 2002: reducing risks, promoting healthy life. Geneva, Switzerland: World Health Organisation, 2002:1\u2013230.","DOI":"10.1080\/1357628031000116808"},{"key":"2025112109171759000_66.1.145.2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200524282"},{"key":"2025112109171759000_66.1.145.3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.12703\/P6-95","article-title":"Future therapy of portal hypertension in liver cirrhosis\u2014a guess","volume":"6","author":"Sauerbruch","year":"2014","journal-title":"F1000 Prime Rep"},{"key":"2025112109171759000_66.1.145.4","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.144584"},{"key":"2025112109171759000_66.1.145.5","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.03.003"},{"key":"2025112109171759000_66.1.145.6","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3823"},{"key":"2025112109171759000_66.1.145.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70368-4"},{"key":"2025112109171759000_66.1.145.8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2003.01251.x"},{"key":"2025112109171759000_66.1.145.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2005.01053.x"},{"key":"2025112109171759000_66.1.145.10","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27117"},{"key":"2025112109171759000_66.1.145.11","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2079"},{"key":"2025112109171759000_66.1.145.12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21673"},{"key":"2025112109171759000_66.1.145.13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23222"},{"key":"2025112109171759000_66.1.145.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.04.025"},{"key":"2025112109171759000_66.1.145.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.07.033"},{"key":"2025112109171759000_66.1.145.16","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-308338"},{"key":"2025112109171759000_66.1.145.17","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-308800"},{"key":"2025112109171759000_66.1.145.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2014.12.017"},{"key":"2025112109171759000_66.1.145.19","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.029"},{"key":"2025112109171759000_66.1.145.20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21502"},{"key":"2025112109171759000_66.1.145.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.09.008"},{"key":"2025112109171759000_66.1.145.22","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.226407"},{"key":"2025112109171759000_66.1.145.23","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22170"},{"key":"2025112109171759000_66.1.145.24","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.06.036"},{"key":"2025112109171759000_66.1.145.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00750.x"},{"key":"2025112109171759000_66.1.145.26","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.2741\/3058","article-title":"Novel aspects of the renin-angiotensin-aldosterone-system","volume":"13","author":"Wolf","year":"2008","journal-title":"Front Biosci"},{"key":"2025112109171759000_66.1.145.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2011.11.019"},{"key":"2025112109171759000_66.1.145.28","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200318212"},{"issue":"(Suppl 1)","key":"2025112109171759000_66.1.145.29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-8278(00)80422-5","article-title":"Complications of cirrhosis. I. Portal hypertension","volume":"32","author":"Bosch","year":"2000","journal-title":"J Hepatol"},{"key":"2025112109171759000_66.1.145.30","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.020263"},{"key":"2025112109171759000_66.1.145.31","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.17.5.2497"},{"key":"2025112109171759000_66.1.145.32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI66028"},{"key":"2025112109171759000_66.1.145.33","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.081059"},{"key":"2025112109171759000_66.1.145.34","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00196.2006"},{"key":"2025112109171759000_66.1.145.35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002028"},{"key":"2025112109171759000_66.1.145.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2012.08.005"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2015-309600","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:17:22Z","timestamp":1763745442000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2015-309600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,17]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,7]]},"published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.1136\/gutjnl-2015-309600"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2015-309600","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,17]]}}}